Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Femasys Inc. stock logo
FEMY
Femasys
$0.80
$1.10
$0.69
$1.80
$21.79M-2.62251,041 shs288,249 shs
FONAR Co. stock logo
FONR
FONAR
$14.50
+0.3%
$12.98
$12.00
$18.68
$89.94M116,903 shs16,002 shs
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$2.52
+3.3%
$2.66
$1.92
$4.21
$89.93M0.74248,253 shs23,565 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.50
-3.8%
$2.53
$2.07
$3.80
$79.65M0.5938,611 shs66,585 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Femasys Inc. stock logo
FEMY
Femasys
0.00%-21.57%-29.82%-46.67%-27.93%
FONAR Co. stock logo
FONR
FONAR
+0.35%+0.69%+19.15%+2.91%-7.47%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
+3.28%-0.40%-7.18%+5.00%+8.62%
InspireMD, Inc. stock logo
NSPR
InspireMD
-3.85%-2.34%-0.79%-11.97%-7.41%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Femasys Inc. stock logo
FEMY
Femasys
3.5803 of 5 stars
3.55.00.00.02.22.51.3
FONAR Co. stock logo
FONR
FONAR
2.2785 of 5 stars
0.05.00.00.02.90.81.9
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
3.4586 of 5 stars
3.85.00.00.03.01.70.6
InspireMD, Inc. stock logo
NSPR
InspireMD
2.835 of 5 stars
3.55.00.00.00.62.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Femasys Inc. stock logo
FEMY
Femasys
3.00
Buy$8.67983.33% Upside
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
3.50
Strong Buy$5.40114.29% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5080.00% Upside

Current Analyst Ratings Breakdown

Latest FEMY, FONR, MGRM, and NSPR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
Femasys Inc. stock logo
FEMY
Femasys
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $6.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
5/9/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
3/28/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
3/19/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $15.00
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$5.40
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.00 ➝ $5.40
3/13/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
(Data available from 6/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Femasys Inc. stock logo
FEMY
Femasys
$1.70M12.82N/AN/A$0.85 per share0.94
FONAR Co. stock logo
FONR
FONAR
$103.02M0.87$3.03 per share4.78$25.62 per share0.57
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$365.00K246.39N/AN/A$0.43 per share5.86
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M10.90N/AN/A$1.83 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Femasys Inc. stock logo
FEMY
Femasys
-$14.25M-$0.91N/AN/AN/A-1,435.77%-141.49%-82.30%8/14/2025 (Estimated)
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.2512.61N/A7.68%4.94%3.70%N/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$13.74M-$0.45N/AN/AN/AN/A-130.90%-106.38%8/13/2025 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A

Latest FEMY, FONR, MGRM, and NSPR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q3 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.37N/A$0.37N/AN/A
5/14/2025Q1 2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.12-$0.10+$0.02-$0.10N/AN/A
5/8/2025Q1 2025
Femasys Inc. stock logo
FEMY
Femasys
-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 million
3/27/2025Q4 2024
Femasys Inc. stock logo
FEMY
Femasys
-$0.25-$0.23+$0.02-$0.23$1.66 million$0.58 million
3/12/2025Q4 2024
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.11-$0.08+$0.03-$0.08N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Femasys Inc. stock logo
FEMY
Femasys
N/AN/AN/AN/AN/A
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Femasys Inc. stock logo
FEMY
Femasys
0.86
3.94
3.26
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/A
7.31
7.31
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05

Institutional Ownership

CompanyInstitutional Ownership
Femasys Inc. stock logo
FEMY
Femasys
65.27%
FONAR Co. stock logo
FONR
FONAR
50.64%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
0.45%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%

Insider Ownership

CompanyInsider Ownership
Femasys Inc. stock logo
FEMY
Femasys
11.54%
FONAR Co. stock logo
FONR
FONAR
1.55%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
28.10%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Femasys Inc. stock logo
FEMY
Femasys
3027.24 million20.08 millionNot Optionable
FONAR Co. stock logo
FONR
FONAR
4806.20 million6.19 millionNot Optionable
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
2835.69 million24.67 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable

Recent News About These Companies

InspireMD Hires New Financial Chief
InspireMD appoints Michael Lawless CFO
InspireMD Q1 2025 Earnings Preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

Femasys stock logo

Femasys NASDAQ:FEMY

$0.80 0.00 (0.00%)
Closing price 06/5/2025 04:00 PM Eastern
Extended Trading
$0.81 +0.01 (+1.38%)
As of 06/5/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

FONAR stock logo

FONAR NASDAQ:FONR

$14.50 +0.05 (+0.35%)
Closing price 06/5/2025 04:00 PM Eastern
Extended Trading
$14.51 +0.01 (+0.10%)
As of 06/5/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Monogram Orthopaedics stock logo

Monogram Orthopaedics NASDAQ:MGRM

$2.52 +0.08 (+3.28%)
Closing price 06/5/2025 04:00 PM Eastern
Extended Trading
$2.52 0.00 (0.00%)
As of 06/5/2025 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.50 -0.10 (-3.85%)
Closing price 06/5/2025 04:00 PM Eastern
Extended Trading
$2.54 +0.04 (+1.80%)
As of 06/5/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.